Hyperglycemia-induced oxidative stress in diabetic complications

Reactive oxygen species are increased by hyperglycemia. Hyperglycemia, which occurs during diabetes (both type 1 and type 2) and, to a lesser extent, during insulin resistance, causes oxidative stress. Free fatty acids, which may be elevated during inadequate glycemic control, may also be contributory. In this review, we will discuss the role of oxidative stress in diabetic complications. Oxidative stress may be important in diabetes, not just because of its role in the development of complications, but because persistent hyperglycemia, secondary to insulin resistance, may induce oxidative stress and contribute to beta cell destruction in type 2 diabetes. The focus of this review will be on the role of oxidative stress in the etiology of diabetic complications.

[1]  A. Kennedy,et al.  Therapeutic potential of anti-oxidants and diabetic retinopathy , 2001, Expert opinion on investigational drugs.

[2]  N. Perico,et al.  Endothelin antagonists and renal protection. , 2000, Journal of cardiovascular pharmacology.

[3]  G. King,et al.  Biochemical and Molecular Mechanisms in the Development of Diabetic Vascular Complications , 1996, Diabetes.

[4]  U. Eriksson,et al.  Pregnant Diabetic Rats Fed the Antioxidant Butylated Hydroxytoluene Show Decreased Occurrence of Malformations in Offspring , 1996, Diabetes.

[5]  R. Gaynor,et al.  Role of the NF-kappaB pathway in the pathogenesis of human disease states. , 2001, Current molecular medicine.

[6]  V. Ferrans,et al.  Role for Mitochondrial Oxidants as Regulators of Cellular Metabolism , 2000, Molecular and Cellular Biology.

[7]  H. Hammes,et al.  Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy , 2003, Nature Medicine.

[8]  O. Pedersen,et al.  Double‐blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type 2 diabetic patients , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[9]  S. Bursell,et al.  Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor , 1996, Science.

[10]  T. Finkel,et al.  Redox Regulation of Cdc25C* , 2002, The Journal of Biological Chemistry.

[11]  E. Cagliero,et al.  Altered levels of scavenging enzymes in embryos subjected to a diabetic environment. , 1996, Free radical research.

[12]  S. Bursell,et al.  Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. , 1995, The American journal of physiology.

[13]  S. Yusuf,et al.  Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. , 2002, Diabetes care.

[14]  K. Kraemer,et al.  Molecular aspects of lipoic acid in the prevention of diabetes complications. , 2001, Nutrition.

[15]  S. Shin,et al.  Decrease of renal endothelin 1 content and gene expression in diabetic rats with moderate hyperglycemia. , 1995, Nephron.

[16]  I. G. Fantus,et al.  The hexosamine pathway regulates the plasminogen activator inhibitor-1 gene promoter and Sp1 transcriptional activation through protein kinase C-beta I and -delta. , 2002, The Journal of biological chemistry.

[17]  Y. Kaneda,et al.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.

[18]  J. Hancock,et al.  Role of reactive oxygen species in cell signalling pathways. , 2001, Biochemical Society transactions.

[19]  P. McDonagh,et al.  Microvascular Perfusion and Transport in the Diabetic Heart , 2000, Microcirculation.

[20]  J. Baynes,et al.  Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. , 1999, Diabetes.

[21]  U. Eriksson,et al.  Vitamin C supplementation of the maternal diet reduces the rate of malformation in the offspring of diabetic rats , 1997, Diabetologia.

[22]  Jared Rutter,et al.  Regulation of Clock and NPAS2 DNA Binding by the Redox State of NAD Cofactors , 2001, Science.

[23]  E. Reece,et al.  Dietary vitamin E prophylaxis and diabetic embryopathy: morphologic and biochemical analysis. , 1996, American journal of obstetrics and gynecology.

[24]  A. Vinik,et al.  Diabetic neuropathies , 2000, Diabetologia.

[25]  L. Lanting,et al.  Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. , 1997, The American journal of physiology.

[26]  U. Eriksson,et al.  Vitamin E Decreases the Occurrence of Malformations in the Offspring of Diabetic Rats , 1997, Diabetes.

[27]  L. Aiello,et al.  High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. , 1999, Diabetes care.

[28]  K. Sharma,et al.  Potential Role of TGF-β in Diabetic Nephropathy , 1998, Mineral and Electrolyte Metabolism.

[29]  H. E. Marshall,et al.  Nitrosation and oxidation in the regulation of gene expression , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  R. Grossman,et al.  Ischemic injury and faulty gene transcripts in the brain , 2001, Trends in Neurosciences.

[31]  M. Buse,et al.  alpha-Lipoic acid prevents the development of glucose-induced insulin resistance in 3T3-L1 adipocytes and accelerates the decline in immunoreactive insulin during cell incubation. , 2001, Metabolism: clinical and experimental.

[32]  L. Aiello,et al.  Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. , 1996, The Journal of clinical investigation.

[33]  I. Chang,et al.  Pyruvate inhibits zinc-mediated pancreatic islet cell death and diabetes , 2003, Diabetologia.

[34]  V. Ferrans,et al.  Requirement for Generation of H2O2 for Platelet-Derived Growth Factor Signal Transduction , 1995, Science.

[35]  N. Ruderman,et al.  Lipid-Induced Insulin Resistance in Human Muscle Is Associated With Changes in Diacylglycerol, Protein Kinase C, and IκB-α , 2002 .

[36]  W. R. Carper,et al.  A kinetic study of glucose-6-phosphate dehydrogenase. , 1976, The Journal of biological chemistry.

[37]  S. Nagataki,et al.  Significance of Glutathione Depletion and Oxidative Stress in Early Embryogenesis in Glucose-Induced Rat Embryo Culture , 1995, Diabetes.

[38]  L. Pfeffer,et al.  NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase , 1999, Nature.

[39]  H. Makino,et al.  Increased gene expression of insulin-like growth factor-i receptor in experimental diabetic rat glomeruli. , 1996, Nephron.

[40]  S. Bursell,et al.  Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. , 1996, Science.

[41]  G. FitzGerald,et al.  Oxidative Stress and Cardiovascular Injury: Part I: Basic Mechanisms and In Vivo Monitoring of ROS , 2003, Circulation.

[42]  N. Kaplowitz,et al.  Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes. , 1995, Molecular pharmacology.

[43]  M. Dunnwald,et al.  Leprdb Diabetic Mouse Bone Marrow Cells Inhibit Skin Wound Vascularization but Promote Wound Healing , 2003, Circulation research.

[44]  A. Kong,et al.  Antioxidants and oxidants regulated signal transduction pathways. , 2002, Biochemical pharmacology.

[45]  U. Eriksson,et al.  Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture , 1997, Diabetologia.

[46]  H. Luthman,et al.  Increased mRNA levels of Mn-SOD and catalase in embryos of diabetic rats from a malformation-resistant strain. , 2000, Diabetes.

[47]  R. Roeder,et al.  S Phase Activation of the Histone H2B Promoter by OCA-S, a Coactivator Complex that Contains GAPDH as a Key Component , 2003, Cell.

[48]  C. Napoli,et al.  Multiple role of reactive oxygen species in the arterial wall , 2001, Journal of cellular biochemistry.

[49]  M. Loeken,et al.  Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects , 2003, Diabetologia.

[50]  A. Goldfine,et al.  Ascorbate Restores Endothelium-Dependent Vasodilation Impaired by Acute Hyperglycemia in Humans , 2001, Circulation.

[51]  M. Brown,et al.  A Randomised Controlled Trial of Vitamin E in Patients with Coronary Disease: The Cambridge Heart Antioxidant Study (CHAOS) , 1996 .

[52]  V. Nicoletti,et al.  Role of PARP Under Stress Conditions: Cell Death or Protection? , 2003, Neurochemical Research.

[53]  M. Dunlop,et al.  Aldose reductase and the role of the polyol pathway in diabetic nephropathy. , 2000, Kidney international. Supplement.

[54]  R. Somwar,et al.  The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation. , 2001, Diabetes.

[55]  L. Borg,et al.  Altered metabolism and superoxide generation in neural tissue of rat embryos exposed to high glucose. , 1997, The American journal of physiology.

[56]  M. Catherwood,et al.  Glucose-induced oxidative stress in vascular contractile cells: comparison of aortic smooth muscle cells and retinal pericytes. , 1998, Diabetes.

[57]  G. King,et al.  Vitamin E Normalizes Diacylglycerol—Protein Kinase C Activation Induced by Hyperglycemia in Rat Vascular Tissues , 1996, Diabetes.

[58]  E. Feldman,et al.  Pathogenesis of diabetic neuropathy. , 1989, Clinical neuroscience.

[59]  M. Oren,et al.  Decision making by p53: life, death and cancer , 2003, Cell Death and Differentiation.

[60]  U. Eriksson,et al.  Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro. , 1998, Diabetes.

[61]  G. King,et al.  Characterization of the Mechanism for the Chronic Activation of Diacylglycerol-Protein Kinase C Pathway in Diabetes and Hypergalactosemia , 1994, Diabetes.

[62]  M. Loeken,et al.  Neural Tube Defects in Embryos of Diabetic Mice: Role of the Pax-3 Gene and Apoptosis , 1997, Diabetes.

[63]  D. Tomlinson,et al.  Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy , 2001, Diabetologia.

[64]  I. G. Fantus,et al.  The Hexosamine Pathway Regulates the Plasminogen Activator Inhibitor-1 Gene Promoter and Sp1 Transcriptional Activation through Protein Kinase C-βI and -δ* , 2002, The Journal of Biological Chemistry.

[65]  E. Reece,et al.  Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. , 1995, American journal of obstetrics and gynecology.

[66]  L. Rossetti,et al.  Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. , 2003, The Journal of clinical investigation.

[67]  M. Loeken,et al.  Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. , 1999, Diabetes.

[68]  A. Kashiwagi,et al.  Glycation, Oxidative Stress, and Scavenger Activity: Glucose Metabolism and Radical Scavenger Dysfunction in Endothelial Cells , 1996, Diabetes.

[69]  N. Welsh,et al.  Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment. , 1999, Diabetes.

[70]  H. Utsumi,et al.  High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. , 2000, Diabetes.

[71]  M. Boaz,et al.  Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial , 2000, The Lancet.

[72]  G. Paolisso,et al.  Oxidative Stress and Diabetic Vascular Complications , 1996, Diabetes Care.

[73]  N. Ruderman,et al.  Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. , 2002, Diabetes.

[74]  E. Herrera,et al.  Teratogenic effects of diabetes mellitus in the rat. Prevention by vitamin E , 1996, Diabetologia.

[75]  M. Lagarde,et al.  Involvement of cell-cell interactions in the pathogenesis of diabetic retinopathy. , 1997, Diabetes & metabolism.

[76]  E. Price,et al.  Modulation of CFTR chloride channels by calyculin A and genistein. , 1997, The American journal of physiology.